News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
AC Immune Partner Life Molecular Imaging Initiates Phase 3 Study of Tau PET Diagnostic PI-2620 for Alzheimer’s Disease
Thursday, January 19, 2023AC Immune SA a clinicalstage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases today announced that its collaboration partner Life Molecular Imaging LMI has imaged the first patient in ADvance the pivotal Phase t...
PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
Thursday, January 19, 2023PharmaTher Holdings Ltd a leader in specialty ketamine pharmaceuticals is pleased to announce that it has applied with the US Food and Drug Administration FDA to receive Orphan Drug Designation ODD for ketamine to treat Rett Syndrome a rare genetic n...
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology
Wednesday, January 18, 2023TC Biopharm PLC a clinical stage biotechnology company developing platform allogeneic gammadelta T cell therapies for cancer treatment today announces a strategic collaboration with The University of Texas MD Anderson Cancer Center to expand the know...
Shineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus Group
Wednesday, January 18, 2023Shineco Inc a producer and distributor of Chinese herbal medicines organic agricultural products and other biotech products announced today that on January
PreveCeutical Enters into License Option Agreement with Endosane Pharmaceuticals
Friday, January 13, 2023PreveCeutical Medical Inc is pleased to announce that it has entered into a License Option Agreement with Endosane Pharmaceuticals GmbH Endosane a subsidiary of Sanity Group dated January pursuant to which Endosane has been granted an option to lic...
RespireRx Pharmaceuticals Inc. Establishes ResolutionRx Ltd in Australia to Develop Its Pharmaceutical Cannabinoid Platform
Friday, January 13, 2023RespireRx Pharmaceuticals Inc a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling is pleased to announce that on January it established ResolutionRx Ltd...
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
Wednesday, January 11, 2023Clearmind Medicine Inc a biotech company focused on discovery and development of novel psychedelicderived therapeutics to solve major undertreated health problems announced that it has successfully manufactured batches of its drug candidate MEAIbased...
Virpax Pharmaceuticals Engages Destum Partners to Direct Strategic Global Partnering Efforts
Wednesday, January 11, 2023Virpax Pharmaceuticals Inc a company specializing in developing nonaddictive products for pain management posttraumatic stress disorder central nervous system CNS disorders and viral barrier indications today announced that the Company has engaged De...
AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline
Tuesday, January 10, 2023AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma Inc CinCor a USbased clinicalstage biopharmaceutical company focused on developing novel treatments
Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases
Tuesday, January 10, 2023Ipsen and Albireo announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo a leading innovator in bileacid modulators to treat pediatric and adult cholestatic liver diseases The anticipated acquisitio...
